News

Memphis, TN-Travoprost 0.004% ophthalmic solution (Travatan, Alcon) is an effective IOP-lowering medication in patients of all racial origins. However, travoprost reduces IOP more in black patients compared with non-black patients, and its efficacy in blacks exceeds that associated with both timolol (Timoptic, Merck) and latanoprost (Xalatan, Pharmacia), said Peter A. Netland, MD, PhD.

Cincinnati, OH-The IOP-lowering effect of dorzolamide HCl/timolol maleate (Cosopt, Merck, West Point, PA) is comparable to that of brimonidine tartrate (Alphagan, Allergan, Irvine, CA) and timolol maleate after 6 months of treatment.

Washington, DC-Unoprostone isopropyl 0.15% (Rescula, Novartis) may be a viable option for further lowering IOP in patients with advanced glaucoma whose disease is uncontrolled by maximum tolerated medical therapy, said Leslie S. Jones, MD.

Indianapolis-Pooled 6-month data from two multicenter, double-blind, parallel studies demonstrate that once-daily treatment with bimatoprost ophthalmic solution 0.03% (Lumigan, Allergan) is safe and more effective than timolol 0.5% for controlling elevated IOP, said Louis B. Cantor, MD.

Baltimore-Patients who received latanoprost (Xalatan, Pharmacia Corp., Peapack, NJ) to treat glaucoma were more likely to adhere to their regimens and less likely to discontinue their medications compared with patients who are prescribed beta-blockers, carbonic anhydrase inhibitors, or brimonidine, according to Gail Schwartz, MD, and her colleagues.

Ann Arbor, MI-Quality of life is remarkably similar among patients with newly diagnosed open-angle glaucoma randomly assigned to initial treatment with medication or trabeculectomy, according to Nancy K. Janz, PhD.

N onpenetrating glaucoma surgery in expert hands is as efficacious as trabeculectomy for controlling IOP but results in significantly fewer complications, said Tarek M. Shaarawy, MD.

New Orleans - Based on 5 years of follow-up, medication and filtering surgery both appear to be effective and safe for initiating treatment in eyes with newly diagnosed open-angle glaucoma

A 14-year-old boy presents with new-onset, severe, diffuse headache and blurry vision. He is found to have bilateral "papilledema."

Everything has changed since Sept. 11, as we've so often heard. But some things have remained the same.

Ophthalmologists prescribing timolol hemihydrate (Betimol, Santen Pharmaceuticals) can be assured their patients are receiving a brand-name nonselective beta-blocker product that is safe, effective, and economical, said Michael S. Berlin, MD, and George A. Cioffi, MD.

The American Academy of Ophthalmology (AAO) has issued three patient safety bulletins to improve patient care in ophthalmology. The academy has analyzed three key areas where errors may occur and suggested ways to minimize these medical errors.

Allergan's brimonidine tartrate (Alphagan) will have new labeling that indicates its 0.5% strength is suitable for pediatric patients over 2 years old.

STAAR Surgical Co. announced the FDA has given conditional approval for aninvestigational device exemption for the toric implantable contact lens (ICL).

New Orleans-Safety, reproducibility, and user-friendliness make the Amadeus microkeratome (Allergan) an excellent choice for LASIK flap creation, said Kerry D. Solomon, MD, at the refractive surgery subspecialty day prior to the American Academy of Ophthalmology annual meeting.

New Orleans-The BD K-3000 Microkeratome (Becton Dickinson Ophthalmic Systems, Franklin Lakes, NJ) is a reliable and safe system for flap creation during LASIK, according to Paul Dougherty, MD, medical director, Dougherty Laser Vision Institute, Camarillo, CA.

Heidelberg, Germany-A femtosecond-pulse intrastromal laser microkeratome (20/10 Perfect Vision) may make LASIK flap creation safer and more predictable than it is with mechanical microkeratomes, said Frieder H. Loesel, PhD.

Gulfport, MS-The disposable Flapmaker microkeratome (Refractive Technologies Inc., Cleveland) has been receiving high marks from refractive surgeons since it was introduced almost 4 years ago because of its consistency, ease of use, and sterility.

New Orleans-Keratectomy creation with the automated Summit Krumeich-Barraquer Microkeratome (SKBM, Alcon) results in flaps of predictable diameter and hinge size, smooth beds with well-defined edges, and an intact epithelium, said R. Bruce Grene, MD, at the refractive surgery subspecialty day prior to the American Academy of Ophthalmology annual meeting.

New Orleans-Recently introduced upgrades have further enhanced the versatility and safety of the Hansatome (Bausch & Lomb), but users must recognize that deriving the full benefits of this microkeratome depends greatly on its meticulous care, according to Randy J. Epstein, MD, at the refractive surgery subspecial-ty day held prior to the American Academy of Ophthalmol-ogy annual meeting.

New Orleans-The MK-2000 (Nidek) is an easy-to-use, highly reliable, and safe microkeratome, said Arturo S. Chayet, MD, at the refractive surgery subspecialty day prior to the American Academy of Ophthalmology annual meeting.

Cincinnati, OH-By utilizing the benefits of flare-tip phacoemulsification probes, cat-aract surgeons can substantially increase their intraoperative efficiency, according to Robert Cionni, MD.

New Orleans-The femtosecond laser (Pulsion-FS, IntraLaseCorp.) brings new flexibility and increased safety to lamellar flap creation for LASIK, according to Lee T. Nordan, MD, at the refractive subspecialty day prior to the American Academy of Ophthalmology meeting here last fall.

New Orleans-The automated M2 (Moria) is a simple-to-use, versatile microkeratome that surgeons can rely on to create reproducibly thick flaps, said James J. Salz, MD, at the refractive surgery subspecialty day prior to the American Academy of Ophthalmology annual meeting.

Galveston, TX-Three-times-a-day treatment with famciclovir (Famvir, Novartis) was as effective against ophthalmic herpes zoster as five-times-a-day acyclovir (Zovirax, Glaxo Wellcome) in a major international trial, said Stephen K. Tyring, MD, PhD.

Atlanta-The longest follow-up to date of a large number of LASIKpatients has given convincing evidence that the procedure does not damagethe corneal endothelium, said Henry F. Edelhauser, PhD.

Infrared video tracking system leads to more predictable correction,less need for enhancements

Studies show potential problems, but many questions remain unanswered

The innovative technology of Bausch & Lomb's Millennium Microsurgicalplatform takes another surge upward with the addition of its new Burst Modesoftware and a retooling of its already highly touted Dual Linear foot pedal.

System enhancements may put surgery times closer to standard phaco fordense cataract